According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are $15.53 Billion USD. In 2025 the company made an earning of $5.23 Billion USD, an increase over its 2024 earnings that were of $4.77 Billion USD. The earnings displayed on this page is the company's Pretax Income.